Ex Vivo Analysis of Human Memory B Lymphocytes Specific for A and B Influenza Hemagglutinin by Polychromatic Flow-Cytometry

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Bardelli, Monia ^a   Alleri, Liliana ^a   Angiolini, Francesca ^a,c   Buricchi, Francesca ^a   Tavarini, Simona ^a   Sammicheli, Chiara ^a   Nuti, Sandra ^a   Degl'Innocenti, Elena ^b   Isnardi, Isabelle ^b   Fragapane, Elena ^a   Del Giudice, Giuseppe ^a   Castellino, Flora ^a   Galli, Grazia ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b NOVARTIS PHARMA AG   (Switzerland)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CD27 ANTIGEN; FLUOROCHROME; IMMUNOGLOBULIN G; VIRUS HEMAGGLUTININ;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FLOW CYTOMETRY; GENE SEQUENCE; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MEMORY CELL; MOLECULAR CLONING; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMABLAST; POLYCHROMATIC FLOW CYTOMETRY; PROTEIN BINDING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; STEM CELL; STRAIN DIFFERENCE; VACCINATION; VIRUS GENE;

ANTIBODIES, NEUTRALIZING; B-LYMPHOCYTES; CELL SEPARATION; CROSS REACTIONS; FLOW CYTOMETRY; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PROTEIN BINDING; SINGLE-DOMAIN ANTIBODIES;

EID: 84881562064     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070620     Document Type: Article

References (29)

1. Yu X, Tsibane T, McGraw PA, House FS, Keefer CJ, et al. (2008) Neutralizing antibodies derived from the B-cells of 1918 influenza pandemic survivors. Nature 455 (7212):: 532-6.
2. Amanna IJ, Carlson NE, Slifka MK, (2007) Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 357 (19):: 1903-15.
3. Sasaki S, Jaimes MC, Holmes TH, Dekker CL, Mahmood K, et al. (2007) Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 81 (1):: 215-28.
4. Ellebedy AH, Ahmed R, (2012) Re-engaging cross-reactive memory B-cells: the influenza puzzle. Front Immunol 3: 53.
5. Dormitzer PR, Galli G, Castellino F, Golding H, Khurana S, et al. (2011) Influenza vaccine immunology. Immunol Rev 239 (1):: 167-77.
6. Wrammert J, Smith K, Miller J, Langley WA, Kokko K, et al. (2008) Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453 (7195):: 667-71.
7. Pinna D, Corti D, Jarrossay D, Sallusto F, Lanzavecchia A, (2009) Clonal dissection of the human memory B-cell repertoire following infection and vaccination. Eur J Immunol 39 (5):: 1260-70.
8. Moody MA, Zhang R, Walter EB, Woods CW, Ginsburg GS, et al. (2011) H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. PLoS One 6 (10):: e25797.
9. Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, et al. (2011) Broadly cross-reactive antibodies dominate the human B-cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 208 (1):: 181-93.
10. Li GM, Chiu C, Wrammert J, McCausland M, Andrews SF, et al. (2012) Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B-cells. Proc Natl Acad Sci U S A 109 (23):: 9047-52.
11. He XS, Sasaki S, Baer J, Khurana S, Golding H, et al. (2012) Heterovariant Cross-Reactive B-Cell Responses Induced by the 2009 Pandemic Influenza Virus A Subtype H1N1 Vaccine. J Infect Dis 207 (2):: 288-96.
12. Faenzi E, Zedda L, Bardelli M, Spensieri F, Borgogni E, et al. (2012) One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies. Vaccine 30 (27):: 4086-94.
13. Doucett VP, Gerhard W, Owler K, Curry D, Brown L, et al. (2005) Enumeration and characterization of virus-specific B-cells by multicolor flow-cytometry. J Immunol Methods 303 (1-2):: 40-52.
14. Dreyfus C, Laursen NS, Kwaks T, Zuijdgeest D, Khayat R, (2012) Highly conserved protective epitopes on influenza B viruses. Science 337 (6100):: 1343-8.
15. Hu W, Chen A, Miao Y, Xia S, Ling Z, et al. (2012) Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B-cells of a 2009 pandemic H1N1 influenza vaccine recipient. Virology 435 (2):: 320-8.
16. Viswanathan K, Chandrasekaran A, Srinivasan A, Raman R, Sasisekharan V, et al. (2010) Glycans as receptors for influenza pathogenesis. Glycoconj J 27: 561-570.
17. Kamerling J P, Makovitzky J, Schauer R, Vliegenthart JF, Wember M, (1982) The nature of sialic-acids in human lymphocytes. Biochimica et Biophysica acta 714: 351-355.
18. Zimmer G, Suguri T, Reuter G, Yu RK, Schauer R, et al. (1994) Modification of sialic-acids by 9-O-acetylation is detected in human leucocytes using the lectin property of influenza C virus. Glycobiology 4: 343-349.
19. Shibuya N, Goldstein IJ, Broekaert WF, Nsimba-Lubaki M, Peeters B, et al. (1987) The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. The Journal of Biological Chemistry 262 (4):: 1596-601.
20. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, et al. (2003) Predominant autoantibody production by early human B cell precursors. Science 301 (5638):: 1374-7.
21. Tiller T, Meffre E, Yurasov S, Tsuiji M, Nussenzweig MC, et al. (2008) Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. J Immunol Methods 329 (1-2):: 112-24.
22. Feshchenko E, Rhodes D, Felberbaum R, McPherson C, Rininger J, et al. (2012) Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability. BMC Biotechnol 12 (1):: 77.
23. Naito Y, Takematsu H, Koyama S, Miyake S, Yamamoto H, et al. (2007) Germinal Center Marker GL7 Probes Activation-Dependent Repression of N-Glycolylneuraminic Acid, a Sialic-acid Species Involved in the Negative Modulation of B-Cell Activation. Mol Cell Biol 27 (8):: 3008-3022.
24. Crotty S, Aubert RD, Glidewell J, Ahmed R, (2004) Tracking human antigen-specific memory B-cells: a sensitive and generalized ELISPOT system. J Immunol Methods 286 (1-2):: 111-22.
25. Galli G, Medini D, Borgogni E, Zedda L, Bardelli M, et al. (2009) Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. Proc Natl Acad Sci U S A 106 (10):: 3877-82.
26. Berkowska MA, Driessen GJ, Bikos V, Grosserichter-Wagener C, Stamatopoulos K, et al. (2011) Human memory B-cells originate from three distinct germinal center-dependent and-independent maturation pathways. Blood 118 (8):: 2150-8.
27. Krystal M, Elliott RM, Benz EW Jr, Young JF, Palese P, (1982) Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proc Natl Acad Sci U S A (15): pp. 4800-4.
28. Schild GC, Dowdle WR (1975) in The Influenza viruses and Influenza. Ed Kilbourne ED (Academic New York).pp 315-372.
29. Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, et al. (2011) A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333 (6044):: 850-6.